The science of dermatology is continually evolving with new technologies and treatments. But in the background, the landscape of medical billing is changing at the same rate. For dermatology practices that want to be financially and operationally efficient in 2025, you have to get ahead of the curve.
Being up to date on the most recent coding updates, compliance regulations, and payer trends is the key to having a thriving revenue cycle versus one that’s bogged down with denials and delays. It’s the small stuff, and ignoring it can significantly affect your bottom line. Let’s take a deep dive into 5 of the most significant dermatology billing updates your practice must adapt to this year.
1. Teledermatology Billing Has Become a New Normal
The pandemic is behind us, but telehealth is not going anywhere. In 2025, billing rules for virtual visits have settled in, and practices need to be accurate. The main point to remember is that most payers, including Medicare, have settled into using the standard office E/M codes for real-time, synchronous telehealth visits permanently. But accurately coding for virtual care takes two essential pieces:
- Modifier 95: Add this to the E/M code to indicate the service was rendered through synchronous video and audio. Omitting this modifier is a quick route to denial.
- Place of Service (POS) Code: Bill POS 10 if the patient was at home or POS 02 if they were at another originating site. The use of POS 11 (Office) is a frequent error in virtual dermatology billing.
Whereas payment parity (reimbursing telehealth at the same level as in-person visits) is well-supported, it may still differ by state and by payer. Aggressive verification of eligibility and benefits is the best practice for every dermatology practice.
2. Payer Scrutiny on Modifiers is Increasing
If your practice performs procedures on the same day as an evaluation and management (E/M) service, you quickly realize the importance of Modifier 25. The modifier shows that the E/M service was substantial and independently identifiable from the procedure. Likewise, Modifier 59 is utilized to mark a unique procedural service. In 2025, payers are employing more advanced software and data analysis to identify what they believe is the misuse or overuse of these modifiers.
Ironclad documentation is the only defense. Your note should clearly indicate the history of why the E/M service was separable from the procedure. It should indicate the medical decision-making complexity and why it exceeded the normal pre-operative work of the procedure itself. Without justification in your notes, appealing a denial becomes almost impossible.
3. Ongoing Refinement of Documentation Standards
The change to E/M coding based on Medical Decision Making (MDM) is a few years old at this point, but its meaning is still being refined. In 2025, it’s all about the quality and clarity of your MDM documentation.
Payers want to see a line of reasoning in your notes. The records should readily justify the level of MDM you are billing for: high, moderate, low, or straightforward complexity. This means documenting:
- The number and complexity of issues resolved.
- The amount and/or complexity of data reviewed and analyzed.
- The risk of complications or morbidity/mortality of the patient.
Merely listing diagnoses is not sufficient. Your documentation needs to capture the cognitive work and effort. A modest investment in contracting with experts to document MDM adequately can yield tremendous returns in avoiding downcoding during audits and proper dermatology billing.
4. Prior Authorizations are More Complex
Dermatology leads the way in applying cutting-edge biologic drugs and other costly treatments to disease states. Although the treatments revolutionize patients’ lives, they are accompanied by a serious administrative challenge: prior authorizations.
In 2025, payers are making the requirements for these approvals more stringent. They frequently require more detailed clinical documentation, evidence of unsuccessful alternative therapies (step therapy), and particular diagnostic codes. The process is taking longer and is a big pain point affecting both patient care and the medical billing process. Dermatology practices are addressing this by:
- Outsourcing prior authorization operations to trained experts.
- Utilizing software and payer portals to streamline submissions.
- Developing standardized documentation templates to ensure all necessary information is included from the start.
5. Price Transparency
The No Surprises Act (NSA) is now fully incorporated into healthcare. In dermatology, this has the greatest effect on self-pay patients and out-of-network treatment. Your practice should have an assured system for issuing Good Faith Estimates (GFEs) to self-pay or uninsured patients for every service scheduled.
The estimate should list the estimated charges for the visit and any procedures expected to be performed. Additionally, adherence to the NSA involves not balance-billing patients for out-of-network services in emergency cases, although this is less typical in a normal dermatology practice.
This movement towards transparency alters the economics of your dermatology practice. It’s a chance to streamline operations by outsourcing dermatology billing to specialists. A smooth medical billing process is an integral part of the patient experience in 2025.
In 2025, navigating the changing dermatology billing landscape requires strategic vision in addition to compliance. Businesses are setting themselves up for long-term success by embracing technology, investing in correct paperwork, and collaborating with professional billing specialists. The aim is not just to avoid denials but to build a robust revenue cycle that promotes clinical excellence and patient satisfaction. Your billing procedures should develop in tandem with dermatology’s ongoing innovations because a successful back office leads to a thriving front office.
